2005 Oncology Nursing Drug Handbook is a comprehensive nursing resource for assessment, intervention, and patient education in the administration of oncology drugs. This text reviews drug information from the nurse's point of view, and helps the nurse focus on minimizing toxicity. This essential reference provides valuable information on effective symptom management and chemotherapy administration for the oncology nurse. Updated annually, the 2005 edition includes the following new drugs: pemetrexed, albarelix for injectable suspension, nanoparticle albumin-bound paclitaxel, telithromycin, daptomycin, palifermin, lenalidomide, oblimersen sodium, edrecolomab, PTK787, Suberoylanilide hydroxamic acid (SAHA), palonosetron, cincacalcet HCL. Additioanlly, indications and toxicity data has been updated for individual drugs. A new chapter on molecular targeted therapy presents a concise, easy-to-understand overview of carcinogenesis, metastasis, and molecular targets. For easy access to critical drug information the Oncology Nursing Drug Handbook is now available as a software reference for your Palm or PocketPC handheld device. This software makes vital oncology drug information, including chemotherapeutic regimens, immediately accessible to oncology nurses.